Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes the REMIND study

Current Medical Research and Opinion

Volumn 28, Issue 9, 2012, Pages 1455-1463

  Adolfsson, Peter ^a   Veijola, Riitta ^b   Huot, Celine ^c   Hansen, Helle Doré ^d   Lademann, Jacob Bo ^d   Phillip, Moshe ^e  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF MONTREAL   (Canada)

^d NOVO NORDISK A S   (Denmark)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Half unit dosing; Memory function; Pediatric pen; Preference; Safety

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; CHILD; CLINICAL PROTOCOL; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INJECTION SITE BLEEDING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PEN; INSULIN TREATMENT; ISRAEL; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEMORY; METABOLIC REGULATION; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PHYSICIAN; PRESCHOOL CHILD; QUESTIONNAIRE; SCHOOL CHILD; SIDE EFFECT; SWEDEN;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, INTRAMUSCULAR; INSULIN; MALE; QUESTIONNAIRES;

EID: 84866682191     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.698258     Document Type: Article

References (30)

1. Daneman D. State of the world's children with diabetes. Pediatr Diabetes 2009;10:120-6
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
3. Molife C, Lee LJ, Shi LZ, et al. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. Diabetes Technol Ther 2009;11:529-38
4. Peyrot M; International DAWN Youth Survey Group. The DAWN Youth WebTalk Study: methods, findings, and implications. Pediatr Diabetes 2009;10:37-45
5. Burdick J, Chase HP, Slover RH, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics 2004;113:e221-4
6. Ignaut DA, Venekamp WJ. HumaPen Memoir: a novel insulin-injecting pen with a dose-memory feature. Expert Rev Med Devices 2007;4:793-802
7. Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25
8. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96
9. Rex J, Jensen KH, Lawton SA. A review of 20 years' experience with the NovoPen family of insulin injection devices. Clin Drug Investig 2006;26:367-401
10. Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-61
11. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8, 61-4, 68
12. Tubiana-Rufi N, Levy-Marchal C, Mugnier E, et al. Long term feasibility of multiple daily injections with insulin pens in children and adolescents with diabetes. Eur J Pediatr 1989;149:80-3
13. Silverstein J, Klingensmith G, Copeland K, et al. Care of children and adolescents with type 1 diabetes-a statement of the American Diabetes Association. Diabetes Care 2005;28:186-212
14. Olsen BS, Lilleøre SK, Korsholm CN, et al. Novopen Echo® for the delivery of insulin: a comparison of usability, functionality and preference among pedi-atric subjects, their parents, and health care professionals. J Diabetes Sci Technol 2010;4:1468-75
15. Kristensen CM, Lilleøre SK. Dose accuracy and durability of a durable insulin pen before and after simulated lifetime use. Curr Med Res Opin 2011;27:1877-83
16. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6
17. Niskanen L, Jensen LE, Ra°stam J, et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-40
18. Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31
19. Ou HT, Feldman SR, Balkrishnan R. Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg 2010;29:137-40
20. Randløv J, Poulsen JU. How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study. J Diabetes Sci Technol 2008;2:229-35
21. Jacombs J. Every child matters? Children with type 1 diabetes are being let down by lack of support in school. A report by the UK Children With Diabetes Advocacy Group investigating the range of contemporary educational experiences of children with diabetes at school in the UK, 2007
22. Hanestad BR, Albrektsen G. Quality of life, perceived difficulties in adherence to a diabetes regimen, and blood glucose control. Diabet Med 1991;8:759-64
23. Su CC, Chen HS, Lin HD. Glycemic control with different premixed insulin in Taiwanese people with type two diabetes mellitus. J Chin Med Assoc 2003;66:155-9
24. Asche CV, Shane-McWhorter L, Raparla S. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technol Ther 2010;12(Suppl 1):S101-8
25. Asakura T, Jensen KH. Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol 2009;3:312-19
26. Lee WC, Balu S, Cobden D, et al. Insulin therapy among type 2 diabetes patients: Impact of conversion to a pen device on adherence, hypoglycemic events, and costs. Value Health 2006;9:A187
27. Hood KK, Ronan JM, Peterson CM, et al. Interventions with adherence-promoting components in pediatric type 1 diabetes meta-analysis of their impact on glycemic control. Diabetes Care 2010;33:1658-64
28. Mianowska B, Fendler W, Szadkowska A, et al. HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions. Diabetologia 2011;54:749-56
29. Gerstl EM, Rabl W, Rosenbauer J, et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type 1 diabetes mel-litus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 2008;167:447-53
30. Fatourechi MM, Kudva YC, Murad MH, et al. Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections. J Clin Endocrinol Metab 2009;94:729-40